- The global continuous renal replacement therapy (CRRT) market stood at a modest valuation of US$865 mn in 2018
- This valuation will likely receive a major bump during 2019-2027 forecast period, as the study reveals 13.2 million patients are affected with acute kidney injury disease globally
ALBANY, New York, March 11, 2020 /PRNewswire/ -- Technological advancements continue to pave way for more effective, and efficient treatments for patients with acute kidney disorders. Among these, the software integration remains notable as it helps increase the efficiency, as well as accuracy. Players in the continuous renal replacement therapy market will likely engage in more collaborative innovation during the forecast period, as the acquisition, and R&D remain promising opportunities.
According to TMR analysts, "nanotechnology promises water-saving, and sorbent-based techniques, which will be key drivers for growth in near future. The nanotechnology will also accelerate move towards highly portable devices for the future. Additionally, continuous innovations like AI developments are increasingly used for detection of high risk of imminent deterioration. The lack of privacy, and consent for obtaining sensitive medical information remains a challenge for large private prospectors. This will likely spur demand for algorithm-based analytical systems, which can predict trends, and stay one step ahead in the treatment".
Key Drivers in the Continuous Renal Replacement Therapy Market
Growing need for continuous evaluation of the effectiveness of treatment remains a big opportunity for growth. Big data in software also promises new avenues for growth for players in the continuous renal replacement therapy market. The growing technological advancements in renal therapies, and availability of online tools for real-time data solutions will provide more transparency, and concrete analysis for end-evaluations.
The manufacturers in the continuous renal replacement therapy market are focussing energies on developing automatic smart decision-making devices. The expert decision support systems, and empirical evidence of patient's previous experiences promises to tap into new solutions in the near future.
According to TMR analysts, the healthcare providers in hospitals are adopting new therapies like continuous extracorporeal for critically-ill patients. The pressing need for multi-organ support has and therapies like continuous renal replacement promises more growth. Recent advancement in renal therapies promise relief for patients from hemodynamic tolerance concerns. The next opportunity on the horizon in the continuous renal replacement therapy market lies in modern integrated full-volume pump monitors, and venovenous systems to carry out safe extracorporeal therapies.
Explore a 243 pages report with detailed research, incisive insights, and in-depth country levels estimations. Gain business intelligence on global continuous renal replacement therapy market (Mode: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Haemofiltration (CVVHF), Continuous Venovenous Haemodialysis (CVVHD), and Continuous Venovenous Haemodiafiltration (CVVHDF); Product: Dialysate & Replacement Fluids, Disposables, and Systems; Therapy: Renal, Non-renal, and Combination; End User: Hospitals, Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Global Continuous Renal Replacement Therapy Market: Segment Analysis
Based on mode, the renal replacement therapy market has been segmented into various treatments. Among these, the continuous venovenous hemofiltration segment will likely lead the growth of the market in terms of total revenues. The acceptance of this technology by nephrologists remains the highlight of its growth story
Among products, the disposable segment is likely to dominate growth of the continuous renal replacement therapy. The optimal use of bloodline sets, tubing, and hemofilters, along with high demand for disposables remain key drivers of growth in this segment
Among therapies, the renal segment remained in lead before previously, and is likely to maintain its strong lead during the forecast period. The optimum usage of CRRT machines for renal indication, and widespread availability of CRRT modalities will drive its growth during 2019-2027
Among end users, the hospital segment remains most promising for growth for players in the continuous renal replacement therapy market. The critical importance, and modernisation of ICUs in hospitals remain key drivers for growth.
Global Continuous Renal Replacement Therapy Market: Region-wise Analysis
Europe region will likely dominate regional growth in the continuous renal replacement therapy market. The region is witnessing increasing incidences of acute kidney injuries, and favourable reimbursement framework in the region promises to propel strong growth during the forecast period. The growing funding for R&D in the region also promises new opportunities for global players in the continuous renal replacement therapy market.
On the other hand, Asia Pacific will likely register highest CAGR during the forecast period. The region is home to strong economic growth, and rise in elderly population, along with expansion of healthcare facilities will promise new opportunities for growth in the continuous renal replacement therapy market.
Continuous renal replacement therapy market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study.
Some key players in the global continuous renal replacement therapy market are Key players operating in the global continuous renal replacement therapy market include Baxter International, Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, and Medica SPA.
Global Continuous Renal Replacement Therapy Market: Segmentation
Continuous Renal Replacement Therapy Market by Mode
Slow Continuous Ultrafiltration (SCUF)
Continuous Venovenous Haemofiltration (CVVHF)
Continuous Venovenous Haemodialysis (CVVHD)
Continuous Venovenous Haemodiafiltration (CVVHDF)
Continuous Renal Replacement Therapy Market by Product
Dialysate & Replacement Fluids
Continuous Renal Replacement Therapy Market by Therapy
Continuous Renal Replacement Therapy Market by End User
Continuous Renal Replacement Therapy Market by Region
Rest of North America
Rest of Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East & Africa
Rest of South America
Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:
Hemodynamic Monitoring Devices Market - Due to a growing trend of hospital system digitalization, the integration of monitoring devices with computers is gaining popularity worldwide, including developing nations, which are inclining more toward adoption sophisticated medical care infrastructure. These integrated systems enable critical care unit staffs to simultaneously view multiple patients' parameters on the same machine. This is a key factor driving their popularity.
Renal Services Market - Renal services gives a convincing and opportune possibility to anticipate the kidney diseases. The main task of renal services is to improve impaired renal function. The renal service centers are controlled by a group of experts and their healthcare professionals & consultants. The services incorporate a full scope of end-stage renal illness care and administrations, including different types of dialysis option like hemodialysis, peritoneal dialysis etc.
Acute Kidney Injury Treatment Market - Acute kidney injury, formerly known as acute renal failure, emerged as a prominent disease after the Second World War. Since then, more emphasis has been laid on the types of therapeutics that need to be developed that can effectively treat this ailment. Alkaline phosphatase, gemigliptin, and QPI002 are few therapeutics that are under clinical trial for treating AKI. As research on acute kidney injury gains momentum, new opportunities are likely to emerge. Influenced by a host of multi-pronged factors, the market for acute kidney injury treatment is likely to surpass a valuation of US$ 2.5 billion by the end of 2027.
Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."